The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โABBVโ.
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Number of shares, 3 months chart
Year | Volume (Price x Shares) | Change |
---|---|---|
2025 | $47.79 M | -75.77% |
2024 | $0.19 B | -13.93% |
2023 | $0.22 B | -63.52% |
2022 | $0.62 B | 629.28% |
2021 | $86.13 M | -77.97% |
2020 | $0.39 B | 85.64% |
2019 | $0.21 B | -52.97% |
2018 | $0.44 B | 269.88% |
2017 | $0.12 B | -48.45% |
2016 | $0.23 B | -37.53% |
2015 | $0.37 B | -44.13% |
2014 | $0.67 B | 2387.79% |
2013 | $27.05 M |
Company | FTD volume (3 months) | FTD volume (1 year) | Country |
---|---|---|---|
![]() Pfizer PFE | $28.79 M | $0.35 B | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $14.98 M | $0.27 B | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $26.07 M | $0.20 B | ๐บ๐ธ USA |
![]() Amgen AMGN | $82.72 M | $0.33 B | ๐บ๐ธ USA |
![]() Gilead Sciences GILD | $0.16 B | $0.25 B | ๐บ๐ธ USA |
![]() Biogen BIIB | $7.8 M | $63.66 M | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $97.99 M | $0.32 B | ๐ฌ๐ง UK |
![]() AstraZeneca AZN | $37.71 M | $0.14 B | ๐ฌ๐ง UK |
![]() Neurocrine Biosciences
NBIX | $15.34 M | $31.8 M | ๐บ๐ธ USA |